REGN Regeneron Pharmaceuticals
- Official Name: REGENERON PHARMACEUTICALS, INC.
- Headquarters: 777 Old Saw Mill River Road, TARRYTOWN, NY, 10591 US
- CEO: Leonard S. Schleifer
- Website: regeneron.com
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-15 | 1R | Lost by 1.260 | (2.189) - (0.929) | ||
| 2025-07-16 | 1 | Won by 1.892 | (3.142) - (5.034) | ||
| 2025-07-23 | 2 | Lost by 13.919 | 1.078 - 14.997 | ||
| 2025-07-30 | 3 | Lost by 2.003 | (8.758) - (6.755) | ||
| 2025-08-06 | 4 | Won by 3.849 | 4.711 - 0.862 | ||
| 2025-08-07 | 1R | Won by 4.307 | 0.971 - (3.336) | ||
| 2025-08-13 | 5 | Lost by 10.321 | (2.433) - 7.888 | ||
| 2025-08-20 | 6 | Won by 2.904 | (0.516) - (3.420) | ||
| 2025-08-21 | 2R | Won by 1.491 | 1.128 - (0.363) | ||
| 2025-08-27 | 7 | Lost by 16.285 | (0.652) - 15.633 | ||
| 2025-09-03 | 8 | Lost by 3.526 | (4.016) - (0.490) | ||
| 2025-09-04 | 3R | Won by 2.238 | 0.599 - (1.639) | ||
| 2025-09-10 | 9 | Lost by 2.690 | (1.440) - 1.250 | ||
| 2025-09-11 | 4R | Lost by 0.029 | 2.236 - 2.265 | ||
| 2025-09-17 | 10 | Lost by 1.109 | 5.508 - 6.617 | ||
| 2025-09-24 | 11 | Lost by 1.129 | (1.341) - (0.212) | ||
| 2025-10-01 | 12 | Won by 12.154 | 3.961 - (8.193) | ||
| 2025-10-08 | 13 | Lost by 9.600 | (5.653) - 3.947 | ||
| 2025-10-15 | 14 | Won by 1.654 | 2.155 - 0.501 | ||
| 2025-10-22 | 15 | Won by 8.047 | 1.455 - (6.592) |
Latest News
Benzinga - 2026-08-28
World Health Organization Director General Determined That The Ebola Epidemic In DRC Still Meets Criteria Of Public Health Emergency Of International Concern, But Not Those Of A Pandemic Emergency
https://www.who.int/news/item/28-08-2026-second-meeting-of-the-ihr-emergency-committee-on-the-epidemic-of-ebola-bundibugyo-virus-disease-in-the-democr...
SeekingAlpha - 2026-08-27
Corvus Pharmaceuticals: Steady As She Goes With Strong Footing In Atopic Dermatitis Treatment
Corvus Pharmaceuticals has delivered strong soquelitinib data in atopic dermatitis, driving a significant market rally and a robust cash raise. Learn ...
SeekingAlpha - 2026-08-27
GSK: Still One Of My Top Healthcare Picks
GSK stock outlook: FDA bepirovirsen Oct 26 decision, Phase 3 OCEAN results, and reaffirmed 2026 guidance. Read here for a detailed investment analysis...
Show more
SeekingAlpha - 2026-08-25
Regeneron: Why I Still See Upside After The Rally
Benzinga - 2026-08-24
$100 Invested In Regeneron Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
SeekingAlpha - 2026-08-24
Sanofi: Trump's Vaccine Policy Won't Break The Story
Yahoo - 2026-08-21
Oil Shipper Hits New High; Three Stocks Also Near Pivots
Yahoo - 2026-08-20
How Moderna’s Historic Short Squeeze Upended the AI Chip Trade
Yahoo - 2026-08-20
Regeneron Secures FDA Approval for Rare Genetic Disorder Drug
SeekingAlpha - 2026-08-20
Alvotech: Reiterate Hold On AVT05/AVT06 BLA Resubmissions And Upcoming Catalysts
Yahoo - 2026-08-20
Regeneron to challenge Ipsen as FDA clears bone disease drug
Benzinga - 2026-08-20
Regeneron Secures FDA Approval For Ultra-Rare Bone Disorder Drug
Benzinga - 2026-08-20
Bill Ackman Donates $400 Million in Pershing Square Stock to Build a Research Institute After His Daughter’s Severe Brain Hemorrhage
Yahoo - 2026-08-20
Why Regeneron (REGN) Is Up 5.4% After FDA Approves Pasatru For Ultra-Rare FOP Therapy
Yahoo - 2026-08-19
Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline
Yahoo - 2026-08-19
Regeneron Announces Investor Conference Presentations
Yahoo - 2026-08-19
Is OPK Worth Buying as Valuation Meets Improving Business Trends?
Yahoo - 2026-08-19
Teva Rises 17% YTD: Should You Buy, Sell or Hold the Stock?
Yahoo - 2026-08-19
Biotech Stocks Are Booming. What This Top Fund Is Buying Now.
Yahoo - 2026-08-19
HEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation
SeekingAlpha - 2026-08-19
AstraZeneca Vs. Bristol-Myers Squibb: Who's The Better Bargain For Investors?
Yahoo - 2026-08-18
EyePoint’s Duravyu falls short to Eylea in Phase III trial
Yahoo - 2026-08-18
EYPT Stock Plunges 67% After Duravyu Misses Phase III Eye Disease Goal
Benzinga - 2026-08-18
European Medicines Agency Concerns Prompt Sanofi To Pull Dupixent Indication
Yahoo - 2026-08-16
2 GLP-1 Stocks That Could Double Your Money by 2031
Yahoo - 2026-08-14
GLP-1 Demand Is Soaring. 2 Stocks That Could Benefit From This (Hint: Not Eli Lilly or Novo Nordisk)
Yahoo - 2026-08-14
Is Biohaven (BHVN)’s Latest Regeneron Pharmaceuticals (REGN) Deal a Major Catalyst for its Pipeline?
SeekingAlpha - 2026-08-14
Nektar: Maintaining 'Strong Buy' Rating Due To REZPEG Catalyst, Another Coming
Benzinga - 2026-08-14
If You Invested $1000 In Regeneron Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today
Yahoo - 2026-08-13
Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates
Benzinga - 2026-08-12
Big Pharma's Future Growth Rests on Chinese Science? Expert Says: 'We Can't Ban Our Way Out of This'
Yahoo - 2026-08-11
REGN Soars 21.9% in a Month: Buy, Sell or Hold the Stock?
SeekingAlpha - 2026-08-11
American Century Focused Dynamic Growth Fund Q2 2026 Portfolio Review
Yahoo - 2026-08-08
Regeneron Pharmaceuticals (REGN) Keeps Buybacks And Dividend In Focus As Fair Value Stays In Sight
Yahoo - 2026-08-07
NTLA Q2 Earnings In Line, Top Line Misses on Lower Regeneron Revenues
Yahoo - 2026-08-06
CytomX Therapeutics Q2 Earnings Call Highlights
Yahoo - 2026-08-06
CytomX Therapeutics Announces Q2 2026 Financial Results and Provides Business Update
Yahoo - 2026-08-06
Intellia Therapeutics Inc (NTLA) (Q2 2026) Earnings Call Highlights: Advancing LONVOSI Toward ...
Benzinga - 2026-08-06
LibtayoReceives Health Canada Approval for Adjuvant Treatment Of High-Risk Cutaneous Squamous Cell Carcinoma
Yahoo - 2026-08-05
Surging Earnings Estimates Signal Upside for Regeneron (REGN) Stock
SeekingAlpha - 2026-08-05
Teva Pharmaceuticals: Continuing To Execute On Its 'Pivot To Growth' Plan
Yahoo - 2026-08-05
Ultragenyx's Q2 Earnings Beat Estimates, Revenues Jump Y/Y
Yahoo - 2026-08-05
REGN or INCY: Which Is the Better Value Stock Right Now?
Yahoo - 2026-08-04
BAYRY Beats on Q2 Earnings, Crop Science Business Boosts Growth
SeekingAlpha - 2026-08-04
OPKO Health: Mazdutide And MDX-2201 Could Change Everything
Benzinga - 2026-08-03
Citigroup Maintains Neutral on Regeneron Pharmaceuticals, Raises Price Target to $740
Benzinga - 2026-08-03
6 Health Care Stocks Whale Activity In Today’s Session
Yahoo - 2026-08-03
Biocon Announces U.S. Commercial Launch of Yesafili™, a Biosimilar to Regeneron’s Eylea® 2 mg
Benzinga - 2026-08-03
Guggenheim Maintains Buy on Regeneron Pharmaceuticals, Raises Price Target to $1030
Yahoo - 2026-07-31
S&P 500 ends with its first July decline since 2014. Here are the stocks that led the selloff.
Yahoo - 2026-07-31
Is The Recent Pullback In Alnylam Stock An Opportunity Or A Trap?
Yahoo - 2026-07-31
AbbVie Earnings Beat Forecasts as Skyrizi Sales Soar 24%. Why the Stock Is Falling.
Benzinga - 2026-07-31
RBC Capital Maintains Sector Perform on Regeneron Pharmaceuticals, Raises Price Target to $737
Yahoo - 2026-07-31
AbbVie Bought Apogee to Strengthen Its Portfolio. Now It’s Cutting Earnings Guidance.
Yahoo - 2026-07-31
Company News for July 31, 2026
Benzinga - 2026-07-31
Morgan Stanley Maintains Equal-Weight on Regeneron Pharmaceuticals, Raises Price Target to $758
Yahoo - 2026-07-31
Sanofi to ‘rebuild trust’ with Regeneron; Apnimed adds to string of ‘upsized’ biotech IPOs
Yahoo - 2026-07-31
Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation
Benzinga - 2026-07-31
Cantor Fitzgerald Maintains Overweight on Regeneron Pharmaceuticals, Raises Price Target to $795
Benzinga - 2026-07-31
Wells Fargo Maintains Equal-Weight on Regeneron Pharmaceuticals, Raises Price Target to $750
Benzinga - 2026-07-31
Truist Securities Maintains Buy on Regeneron Pharmaceuticals, Raises Price Target to $772
Yahoo - 2026-07-31
Regeneron Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
Yahoo - 2026-07-30
Regeneron (REGN) Q2 2026 Earnings Call Transcript
Yahoo - 2026-07-30
Regeneron (REGN) Stock Looks Cheap On Earnings Yet Mixed Elsewhere
Yahoo - 2026-07-30
Regeneron Pharmaceuticals Inc (REGN) (Q2 2026) Earnings Call Highlights: Record Dupixent Sales ...
Yahoo - 2026-07-30
Sector Update: Healthcare Stocks Decline Late Afternoon
Yahoo - 2026-07-30
Regeneron Pharmaceuticals Q2 Earnings Call Highlights
Yahoo - 2026-07-30
Sanofi Beats on Q2 Earnings & Sales, Stock Down on Pipeline Setbacks
Yahoo - 2026-07-30
Regeneron Q2 Earnings Beat, Sales Up on Dupixent & Eylea HD Strength
Yahoo - 2026-07-30
Why Regeneron (REGN) Is Up 6.7% After Mixed Q2 Results And New Telix Oncology Deal
SeekingAlpha - 2026-07-30
Regeneron Pharmaceuticals, Inc. (REGN) Q2 2026 Earnings Call Transcript
SeekingAlpha - 2026-07-30
Regeneron Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation
Yahoo - 2026-07-30
Regeneron Beats Second-Quarter Expectations as Dupixent Growth Fuels Strong Results
Yahoo - 2026-07-30
Regeneron (REGN) Q2 Earnings and Revenues Top Estimates
ChartMill - 2026-07-30
Regeneron Pharmaceuticals (NASDAQ:REGN) Surges After Crushing Q2 Estimates with Revenue and EPS Beat
Yahoo - 2026-07-30
Regeneron’s (NASDAQ:REGN) Q2 CY2026: Strong Sales
Yahoo - 2026-07-30
Regeneron Reports Second Quarter 2026 Financial and Operating Results
Yahoo - 2026-07-30
How Telix landed a $2.1 billion radiopharma deal with Regeneron
Benzinga - 2026-07-30
Regeneron Pharmaceuticals Q2 Adj. EPS $14.29 Beats $10.26 Estimate, Sales $4.291B Beat $3.816B Estimate
Yahoo - 2026-07-29
Regeneron (REGN) To Report Earnings Tomorrow: Here Is What To Expect
Yahoo - 2026-07-29
3 Biotech Stocks With Massive Upside to Buy Before August Starts
SeekingAlpha - 2026-07-28
Outlook: 'Hold' - Caution On LYTENAVA FDA Approval And Cash Needs
Yahoo - 2026-07-28
Will REGN's Q2 Earnings Get a Boost From Dupixent and Eylea HD?
Yahoo - 2026-07-27
3 Cash-Heavy Stocks with Questionable Fundamentals
Yahoo - 2026-07-27
Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth
Yahoo - 2026-07-27
Curious about Regeneron (REGN) Q2 Performance? Explore Wall Street Estimates for Key Metrics
SeekingAlpha - 2026-07-24
Regeneron: I'm Not Concerned About The Declining ROIC And Operating Margins
SeekingAlpha - 2026-07-24
Regeneron Q2 Earnings Preview: Not Expecting Miracles - At Least In The Short Term
Benzinga - 2026-07-24
Sanofi Drops Dupixent Successor Candidate After Assessing Data
ChartMill - 2026-07-24
Regeneron Pharmaceuticals (NASDAQ:REGN): A Quality Value Stock with Decent Growth and a Clear Discount
Yahoo - 2026-07-23
Regeneron (REGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Benzinga - 2026-07-21
10 Health Care Stocks With Whale Alerts In Today’s Session
Benzinga - 2026-07-21
Guggenheim Maintains Buy on Regeneron Pharmaceuticals, Raises Price Target to $1000
Yahoo - 2026-07-20
Telix Q2 Revenue US$247M, Strong Momentum and Pipeline Progress
Benzinga - 2026-07-20
Merck Just Won The Race For The First Cholesterol Pill: What It Means For Your Heart And Your Portfolio
SeekingAlpha - 2026-07-20
4D Molecular: 'Buy' Wet-AMD Study Readouts 2027 And DME Expansion Opportunity
Yahoo - 2026-07-20
Biohaven to Present New Clinical Data at ESMO Congress on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload
Yahoo - 2026-07-17
Regeneron Pharmaceuticals (REGN) Rebounds As Undervalued View Holds, Is The Upside Already Priced In?
Yahoo - 2026-07-17
The weight-loss drugs boom is creating both winners and wipeouts: One Big Investment Idea
Yahoo - 2026-07-16
Merck Snags A First-Of-Its-Kind Approval, And Shares Jump
Yahoo - 2026-07-16
Dow Jones' Merck Snags A First-Of-Its-Kind Approval, And Jumps
Yahoo - 2026-07-16
Collect 9.8% On VRTX Stock Now, And Still Keep 15% Of Upside
Yahoo - 2026-07-16
Merck Gets Approval for Powerful Cholesterol-Cutting Pill
SeekingAlpha - 2026-07-15
Longleaf Partners Global Fund Q2 2026 Portfolio Review
Yahoo - 2026-07-14
1 Large-Cap Stock with Exciting Potential and 2 We Turn Down
Yahoo - 2026-07-13
Own Regeneron For Biotech Growth? Incyte Is Making Its Case.
SeekingAlpha - 2026-07-13
Baird International And Global Growth Funds Q2 2026 Contributors And Detractors
Yahoo - 2026-07-13
Disappointing Trial Results Hurt Regeneron Pharmaceuticals (REGN) in Q2
Benzinga - 2026-07-09
Piper Sandler Maintains Overweight on Regeneron Pharmaceuticals, Lowers Price Target to $854
SeekingAlpha - 2026-07-09
Novo Nordisk's Wegovy Pill Escalates Eli Lilly Rivalry
Yahoo - 2026-07-08
Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says
Yahoo - 2026-07-08
Is Regeneron Pharmaceuticals, Inc. (REGN) Stock Still a Biotech Leader After Analyst Price Target Cut?
Benzinga - 2026-07-08
Morgan Stanley Maintains Equal-Weight on Regeneron Pharmaceuticals, Lowers Price Target to $730
Yahoo - 2026-07-08
Collect 9.0% On VRTX Stock Now, And Still Keep 15% Of Upside
Yahoo - 2026-07-07
Jim Cramer Calls Biotech “The Hottest Group in the Market” as He Predicts “Deals Are Going to Be Flooding the Market”
Yahoo - 2026-07-07
Will Regeneron (REGN) Beat Estimates Again in Its Next Earnings Report?
Benzinga - 2026-07-07
RBC Capital Maintains Sector Perform on Regeneron Pharmaceuticals, Lowers Price Target to $696
Benzinga - 2026-07-07
Truist Securities Maintains Buy on Regeneron Pharmaceuticals, Lowers Price Target to $769
Benzinga - 2026-07-07
This Meta Platforms Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Benzinga - 2026-07-07
Benchmark Upgrades Regeneron Pharmaceuticals to Buy, Announces $185 Price Target
Yahoo - 2026-07-06
Can Alnylam's Drug Pipeline Fuel Its Long-Term Revenue Growth?
Benzinga - 2026-07-06
HSBC Maintains Buy on Regeneron Pharmaceuticals, Lowers Price Target to $880
Benzinga - 2026-07-06
Cantor Fitzgerald Maintains Overweight on Regeneron Pharmaceuticals, Lowers Price Target to $750
Yahoo - 2026-07-04
Regeneron (REGN) Stock Looks Undervalued Even After A 20% Gain
Yahoo - 2026-06-30
What Sparked the $43B Jump in AbbVie's Market Cap in the Past Week?
Yahoo - 2026-06-30
FDA PreCheck pilot program selects Eli Lilly, Regeneron
Benzinga - 2026-06-30
Eli Lilly, Regeneron Join FDA Pilot Designed To Accelerate US Manufacturing Readiness
CNBC - 2026-06-30
SCOTUS decisions, Dow at 52,000, the retirement savings gap and more in Morning Squawk
SeekingAlpha - 2026-06-29
Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It
Benzinga - 2026-06-29
'Eli Lilly, Regeneron Among First Companies Selected For FDA Initiative To Speed Review Of New Manufacturing Facilities' - CNBC
CNBC - 2026-06-29
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
ChartMill - 2026-06-29
Hormuz Goes Quiet, Software Wakes Up, and Burry Picks a Side
Yahoo - 2026-06-28
Is Regeneron Pharmaceuticals, Inc. (REGN) Among the Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds?
Yahoo - 2026-06-27
This Little-Known Biotech Just Delivered a Bigger IPO Pop Than SpaceX -- and Regeneron Is Already Invested
CNBC - 2026-06-26
Why BMO's Siegerman says Merck is a top healthcare stock pick
Yahoo - 2026-06-26
Here's Why You Should Add Kiniksa Stock to Your Portfolio Now
Benzinga - 2026-06-26
CDC Raises Its Response Level To Congo Ebola Outbreak To Level 1 Activation, Its Highest Level; Says Risk Of Ebola Spreading In The U.S. Remains Low
SeekingAlpha - 2026-06-26
Beam Therapeutics: A Better Entry Point Is Likely Coming (Rating Downgrade)
Yahoo - 2026-06-25
Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast
Yahoo - 2026-06-25
Is Kymera Therapeutics The Next Big Rival To Regeneron And Sanofi?
Yahoo - 2026-06-25
Is AbbVie a Buy After Its Purchase of Apogee?
Yahoo - 2026-06-24
Will Priority-Reviewed Quarterly siRNA gMG Therapy Change Regeneron Pharmaceuticals' (REGN) Narrative?
Yahoo - 2026-06-23
Regeneron's Applications for gMG Drug Accepted by FDA and EMA
Yahoo - 2026-06-23
Are Biosimilars Becoming a Key Pillar of Amgen's Growth Story?
SeekingAlpha - 2026-06-23
Viatris Soared 54%: Time To Be More Careful (Rating Downgrade)
Yahoo - 2026-06-23
2 Underrated Weight Loss Stocks to Buy and Hold
Yahoo - 2026-06-23
Wells Fargo Maintains Overweight on AbbVie (ABBV), Sees Value in Apogee Acquisition
Yahoo - 2026-06-22
Stock Market Today, June 22: Apogee Therapeutics Soars on AbbVie Cash Buyout Offer
Yahoo - 2026-06-22
The $11 Billion Reason Abbvie Stock Is Up Today
Yahoo - 2026-06-22
AbbVie's $10.9 Billion Apogee Deal Joins a $200 Billion Pharma Spree
Yahoo - 2026-06-22
Why AbbVie Is Spending $11 Billion to Buy Apogee Therapeutics
Yahoo - 2026-06-22
Can Sanofi Rely on Dupixent to Drive Long-Term Revenue Growth?
Yahoo - 2026-06-22
Questex’s DPHARM Announces Senior Leadership and Keynotes for the 16th Annual Conference
Yahoo - 2026-06-22
Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)
Yahoo - 2026-06-20
Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026?
Yahoo - 2026-06-19
Is Sanofi (SNY) A Good Stock To Buy Now?
Yahoo - 2026-06-19
Is CytomX (CTMX) One of the Best Growth Stocks Under $30 to Buy Now?
Yahoo - 2026-06-18
How One Partnership Profit Line Reframes The Regeneron Pharmaceuticals Stock Story
CNBC - 2026-06-18
Obama Center launch brings Democratic political glitterati to Chicago ahead of crucial elections
Benzinga - 2026-06-17
Ocular Therapeutix Maps Regulatory Strategy For Lead Drug Program
Yahoo - 2026-06-17
3 Profitable Stocks We Think Twice About
SeekingAlpha - 2026-06-15
Sanofi 'Strong Buy': Continued Dupxient Sales Growth And Sarclisa OBI First
Benzinga - 2026-06-15
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
SeekingAlpha - 2026-06-12
Regeneron Pharmaceuticals, Inc. (REGN) Shareholder/Analyst Call - Slideshow
Yahoo - 2026-06-12
IMRX Begins Dosing in Phase III Pancreatic Cancer Study, Stock Up
ChartMill - 2026-06-12
REGN (NASDAQ:REGN) Presents a Classic Value Opportunity with Strong Fundamentals
Yahoo - 2026-06-11
Is Regeneron Pharmaceuticals, Inc. (REGN) A Good Stock To Buy Now?
Yahoo - 2026-06-11
Sensorion, citing Regeneron competition, shifts focus to a different hearing loss therapy
Yahoo - 2026-06-10
Parabilis Raises Nearly $745 Million As IPO Demand Surges
Yahoo - 2026-06-10
Parabilis Medicines raises record $670 million in biotech IPO
Yahoo - 2026-06-10
Parabilis sets a record with a $670M biotech IPO
ChartMill - 2026-06-08
Top S&P500 movers in Monday's session
CNBC - 2026-06-08
Regeneron CEO Leonard Schleifer on the power of the Constitution
SeekingAlpha - 2026-06-08
Regeneron Pharmaceuticals, Inc. (REGN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
SeekingAlpha - 2026-06-08
Emergent BioSolutions: Down 40%+ From Recent Highs And Likely More To Come
SeekingAlpha - 2026-06-07
Regeneron: 'Buy' Revenue Growth And Two Extensive Drug Development Opportunities
Yahoo - 2026-06-05
A Look At Regeneron Pharmaceuticals (REGN) Valuation After Expanded CytomX Partnership And Positive Lynozyfic Trial Results
Benzinga - 2026-06-05
U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Response Efforts
Yahoo - 2026-06-05
Parabilis eyes $475m IPO to push lead asset into Phase III
SeekingAlpha - 2026-06-05
Amgen: Time For An Upgrade? Yes, I Think So
Yahoo - 2026-06-04
REGN Expands Cancer Deal With CytomX for Bispecific Therapeutics
Yahoo - 2026-06-04
Sanofi Stock Falls 6% in 3 Months: Should You Buy, Sell or Hold?
Yahoo - 2026-06-04
Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO
Yahoo - 2026-06-04
Regeneron and CytomX extend cancer therapy partnership to $4bn deal
Benzinga - 2026-06-04
Regeneron Pharma To Present New Clinical Data And Research From Its Metabolic Disease, Ophthalmology And Rare Disease Pipelines At ADA 86th Scientific Sessions And ENDO 2026
Yahoo - 2026-06-03
Why Regeneron (REGN) Stock Is Trading Up Today
Yahoo - 2026-06-03
How Investors May Respond To Regeneron (REGN) EMA Fast-Track Review Of Otarmeni Gene Therapy
Yahoo - 2026-06-03
2 S&P 500 Stocks with Solid Fundamentals and 1 We Find Risky
Yahoo - 2026-06-03
CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer
Yahoo - 2026-06-03
NewLimit’s $435M megaround; Lilly’s busy dealmaking week
Yahoo - 2026-06-02
Are Options Traders Betting on a Big Move in Regeneron Stock?
Yahoo - 2026-06-01
3 Nasdaq 100 Stocks We Find Risky
Benzinga - 2026-06-01
10 Health Care Stocks With Whale Alerts In Today's Session
Yahoo - 2026-06-01
Is Regeneron Pharmaceuticals Stock Underperforming the Dow?
Yahoo - 2026-05-31
Regeneron (REGN) Says EMA Accepted Review for Otarmeni Application
Yahoo - 2026-05-29
Regeneron (REGN) Down 12.1% Since Last Earnings Report: Can It Rebound?
Yahoo - 2026-05-28
Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak
Yahoo - 2026-05-28
These 2 Cheap Biotech Stocks Offer Potential for Low-Beta Growth
Yahoo - 2026-05-27
Why Apogee Slipped On Its Dupixent-Rivaling Eczema Results
Yahoo - 2026-05-26
Investment Firm Closes Out Entire $18.1 Million Position in Biotech Stock, According to Latest SEC Filing
Yahoo - 2026-05-26
Canaccord Cuts PT on Regeneron Pharmaceuticals (REGN), Cites a Disappointing Event
Yahoo - 2026-05-26
Are Wall Street Analysts Predicting Regeneron Pharmaceuticals Stock Will Climb or Sink?
CNBC - 2026-05-26
Dr. Scott Gottlieb on Ebola outbreak: This is an outbreak that's out of control in West Africa
Yahoo - 2026-05-25
Regeneron (REGN) Enters $2.32B Collaboration With Parabilis to Target ‘Undruggable’ Proteins
Yahoo - 2026-05-24
Amylyx Stock: Why the Full Pipeline Story Matters
Yahoo - 2026-05-24
Regeneron R&D Updates Test Market View On Long Term Pipeline Value
Yahoo - 2026-05-23
Stocks making big moves this week: Toll Brothers, Booz Allen Hamilton, Strategy, Regeneron, and Micron
Yahoo - 2026-05-22
Otarmeni™ (lunsotogene parvec) Receives EMA Filing Acceptance for Genetic Hearing Loss
SeekingAlpha - 2026-05-21
These Are The Upcoming Catalysts For Crispr Therapeutics Stock
Yahoo - 2026-05-21
Jim Cramer on Regeneron: “There Could Be Some More Downgrades”
SeekingAlpha - 2026-05-21
Apogee Therapeutics: Targeting Atopic Dermatitis
Benzinga - 2026-05-20
$100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth This Much Today
Yahoo - 2026-05-20
Why Regeneron (REGN) Shares Are Trading Lower Today
Yahoo - 2026-05-19
Regeneron & Parabilis Sign Oncology Collaboration Worth Up to $2.2B
Yahoo - 2026-05-19
Can Intellia's Pipeline Push Drive Long-Term Growth Amid Rivalry?
Yahoo - 2026-05-19
A Look At Regeneron Pharmaceuticals (REGN) Valuation After Melanoma Trial Setback And Share Price Pullback
Yahoo - 2026-05-19
Company News for May 19, 2026
Yahoo - 2026-05-19
Why Regeneron Pharmaceuticals (REGN) Is Down 11.7% After Key Melanoma Combo Trial Missed Its Goal
Yahoo - 2026-05-19